特一药业(002728)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002728 特一药业

已收盘 04-16 15:00:00

{"stockData":{"symbol":"002728","market":"SZ","secType":"STK","nameCN":"特一药业","latestPrice":10.96,"timestamp":1776323004000,"preClose":11.09,"halted":0,"volume":16018660,"delay":0,"changeRate":-0.0117,"floatShares":332000000,"shares":513000000,"eps":0.2783,"marketStatus":"已收盘","change":-0.13,"latestTime":"04-16 15:00:00","open":11.02,"high":11.09,"low":10.86,"amount":175000000,"amplitude":0.0207,"askPrice":10.97,"askSize":789,"bidPrice":10.96,"bidSize":1984,"shortable":0,"etf":0,"ttmEps":0.2783,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776389400000},"marketStatusCode":5,"adr":0,"adjPreClose":11.09,"symbolType":"stock","openAndCloseTimeList":[[1776303000000,1776310200000],[1776315600000,1776322800000]],"highLimit":12.2,"lowLimit":9.98,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":513309812,"isCdr":false,"pbRate":3.13,"roa":"--","peRate":39.381962,"roe":"4.55%","epsLYR":0.16,"committee":0.211073,"marketValue":5626000000,"turnoverRate":0.0483,"status":1,"floatMarketCap":3638000000},"requestUrl":"/m/hq/s/002728","defaultTab":"news","newsList":[{"id":"2625260331","title":"股市必读：特一药业（002728）4月3日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2625260331","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625260331?lang=zh_cn&edition=full","pubTime":"2026-04-07 01:24","pubTimestamp":1775496251,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，特一药业报收于11.0元，下跌3.59%，换手率7.87%，成交量26.12万手，成交额2.91亿元。来自公司公告汇总：特一药业全资子公司获硫酸氨基葡萄糖胶囊《药品注册证书》，该产品按（甲类）非处方药管理。公司公告汇总关于举行2025年度网上业绩说明会的公告特一药业集团股份有限公司将于2026年4月13日15:00-17:00在全景网举办2025年度网上业绩说明会，投资者可通过全景网“投资者关系互动平台”参与。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700000610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0201","002728"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624656070","title":"特一药业(002728.SZ)：硫酸氨基葡萄糖胶囊取得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2624656070","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624656070?lang=zh_cn&edition=full","pubTime":"2026-04-03 17:25","pubTimestamp":1775208356,"startTime":"0","endTime":"0","summary":"智通财经APP讯，特一药业(002728.SZ)公告，公司全资子公司海南海力制药有限公司(简称“海力制药”)于近日收到国家药品监督管理局核准签发的硫酸氨基葡萄糖胶囊的《药品注册证书》。硫酸氨基葡萄糖胶囊适用于原发性及继发性骨关节炎。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425107.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"特一药业(002728.SZ)：硫酸氨基葡萄糖胶囊取得药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0201","002728"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624655262","title":"特一药业：销售费用同比增长98.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624655262","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624655262?lang=zh_cn&edition=full","pubTime":"2026-04-03 16:30","pubTimestamp":1775205033,"startTime":"0","endTime":"0","summary":"证券之星消息，特一药业04月03日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，2025年公司净利润大增298%，但销售费用激增98%远超营收增速，请问营销投入具体去向及可持续性？公司2025年销售费用同比增长98.01%，主要因加大数字化营销、市场推广等投入，后续将强化精细化运营，兼顾品牌建设与经营业绩。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300032037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728","BK0201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624507153","title":"特一药业（002728）披露2026年限制性股票激励计划（草案），4月2日股价上涨1.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624507153","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624507153?lang=zh_cn&edition=full","pubTime":"2026-04-02 22:25","pubTimestamp":1775139957,"startTime":"0","endTime":"0","summary":"截至2026年4月2日收盘，特一药业报收于11.41元，较前一交易日上涨1.33%，最新总市值为58.57亿元。该股当日开盘11.26元，最高11.67元，最低11.18元，成交额达4.64亿元，换手率为12.28%。近日，特一药业集团股份有限公司披露《2026年限制性股票激励计划（草案）》。公告显示，本计划拟授予限制性股票总计1,372.9618万股，占公司股本总额的2.67%，其中首次授予1,143.80万股，预留229.1618万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200042582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0201","002728"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624359576","title":"特一药业(002728.SZ)拟授出1372.96万股限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2624359576","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624359576?lang=zh_cn&edition=full","pubTime":"2026-04-01 16:37","pubTimestamp":1775032678,"startTime":"0","endTime":"0","summary":"智通财经APP讯，特一药业(002728.SZ)披露2026年限制性股票激励计划(草案)，激励计划拟向激励对象(首次拟授予的总人数为197人)授予限制性股票总计1372.9618万股(其中首次授予权益1143.80万股)，授予价格(含预留)为7.37元/股。本激励计划的有效期为自首次授予限制性股票登记完成之日起至激励对象获授的限制性股票全部解除限售或回购注销完毕之日止，最长不超过48个月。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423951.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002728","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621084813","title":"股市必读：特一药业（002728）3月23日收盘跌5.03%，主力净流出253.02万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621084813","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621084813?lang=zh_cn&edition=full","pubTime":"2026-03-24 04:09","pubTimestamp":1774296549,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，特一药业报收于10.19元，下跌5.03%，换手率4.7%，成交量17.72万手，成交额1.83亿元。当日关注点来自交易信息汇总：特一药业股价连续3日下跌，3月23日收跌5.03%，主力资金当日净流出253.02万元。股本股东变化因股权激励对象行权，公司股份自2025年6月1日至2025年12月31日增加744,378股，总股本由512,565,434股增至513,309,812股，注册资本相应由512,565,434元变更为513,309,812元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400004708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0201","002728"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621083307","title":"图解特一药业年报：第四季度单季净利润同比增长13.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621083307","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621083307?lang=zh_cn&edition=full","pubTime":"2026-03-24 01:15","pubTimestamp":1774286146,"startTime":"0","endTime":"0","summary":"证券之星消息，特一药业2025年年报显示，当年度公司主营收入9.25亿元，同比上升34.42%；归母净利润8167.16万元，同比上升298.5%；扣非净利润7957.9万元，同比上升328.94%；其中2025年第四季度，公司单季度主营收入2.33亿元，同比上升0.21%；单季度归母净利润1645.45万元，同比上升13.6%；单季度扣非净利润1676.93万元，同比上升3.87%；负债率21.2%，投资收益79.56万元，财务费用178.15万元，毛利率54.62%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400001331.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621703726","title":"特一药业最新公告：2025年净利润同比增长298.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621703726","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621703726?lang=zh_cn&edition=full","pubTime":"2026-03-23 20:20","pubTimestamp":1774268448,"startTime":"0","endTime":"0","summary":"特一药业(002728.SZ)公告称，公司2025年实现营业收入9.25亿元，同比增长34.42%；归属于上市公司股东的净利润为0.82亿元，同比增长298.50%。公司拟向全体股东每10股派发现金红利1.5元(含税)，不送红股，不以公积金转增股本。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300036075.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619245647","title":"特一药业（002728）披露提前归还部分可转债募集资金公告，3月16日股价上涨0.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619245647","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619245647?lang=zh_cn&edition=full","pubTime":"2026-03-16 17:23","pubTimestamp":1773652980,"startTime":"0","endTime":"0","summary":"截至2026年3月16日收盘，特一药业报收于11.2元，较前一交易日上涨0.45%，最新总市值为57.46亿元。近日，特一药业发布《关于提前归还可转债部分暂时补充流动资金的募集资金的公告》。公告显示，公司于2025年5月21日召开董事会，同意使用不超过2,500万元可转债闲置募集资金暂时补充流动资金，期限不超过12个月。截至目前，累计归还1,400万元，剩余1,100万元将在到期前归还。若账户余额不足，公司将及时提前归还，确保募集资金正常支付。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600023990.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","002728","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609253754","title":"异动快报：特一药业（002728）2月6日9点51分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2609253754","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609253754?lang=zh_cn&edition=full","pubTime":"2026-02-06 09:55","pubTimestamp":1770342924,"startTime":"0","endTime":"0","summary":"证券之星2月6日盘中消息，9点51分特一药业触及涨停板。其所属行业中药目前上涨。领涨股为振东制药。该股为中药，长寿药NMN，流感概念热股，当日中药概念上涨1.78%，长寿药NMN概念上涨1.21%，流感概念上涨0.89%。2月5日的资金流向数据方面，主力资金净流入1203.54万元，占总成交额3.31%，游资资金净流入125.5万元，占总成交额0.34%，散户资金净流出1329.04万元，占总成交额3.65%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020600010279.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0239","002728"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606602267","title":"异动快报：特一药业（002728）1月26日9点55分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2606602267","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606602267?lang=zh_cn&edition=full","pubTime":"2026-01-26 10:01","pubTimestamp":1769392872,"startTime":"0","endTime":"0","summary":"证券之星1月26日盘中消息，9点55分特一药业（002728）触及涨停板。其所属行业中药目前下跌。领涨股为康惠股份。该股为流感，长寿药NMN，新冠病毒防治概念热股，当日流感概念上涨1.19%，长寿药NMN概念上涨0.59%。1月23日的资金流向数据方面，主力资金净流入652.82万元，占总成交额1.1%，游资资金净流入157.72万元，占总成交额0.26%，散户资金净流出810.55万元，占总成交额1.36%。近5日资金流向一览见下表：特一药业主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600005420.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0239","002728"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605346237","title":"特一药业：预计2025年全年每股收益盈利:0.14元至0.18元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605346237","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605346237?lang=zh_cn&edition=full","pubTime":"2026-01-22 18:01","pubTimestamp":1769076101,"startTime":"0","endTime":"0","summary":"证券之星消息，特一药业发布业绩预告，预计2025年全年每股收益盈利:0.14元至0.18元。特一药业2025年三季报显示，前三季度公司主营收入6.92亿元，同比上升51.86%；归母净利润6521.71万元，同比上升985.18%；扣非净利润6280.97万元，同比上升2508.06%；其中2025年第三季度，公司单季度主营收入2.01亿元，同比上升41.49%；单季度归母净利润2720.94万元，同比上升719.47%；单季度扣非净利润2472.44万元，同比上升1278.5%；负债率18.81%，投资收益74.87万元，财务费用166.38万元，毛利率56.94%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200030144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728","BK0201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605466272","title":"特一药业(002728.SZ)发预增，预计2025年度归母净利润7000万元—9000万元，同比增长241.55%—339.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605466272","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605466272?lang=zh_cn&edition=full","pubTime":"2026-01-22 16:46","pubTimestamp":1769071591,"startTime":"0","endTime":"0","summary":"智通财经APP讯，特一药业(002728.SZ)披露2025年度业绩预告，公司预计归属于上市公司股东的净利润7000万元—9000万元，同比增长241.55%—339.13%;扣除非经常性损益后的净利润6750万元—8750万元，同比增长263.83%—371.64%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1396152.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"特一药业(002728.SZ)发预增，预计2025年度归母净利润7000万元—9000万元，同比增长241.55%—339.13%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002728"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603982995","title":"股市必读：特一药业（002728）1月15日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2603982995","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603982995?lang=zh_cn&edition=full","pubTime":"2026-01-16 01:13","pubTimestamp":1768497188,"startTime":"0","endTime":"0","summary":"截至2026年1月15日收盘，特一药业报收于11.45元，下跌1.97%，换手率7.01%，成交量26.42万手，成交额3.03亿元。董秘最新回复投资者： 最新的鼻病毒，贵公司有无针对的药物董秘： 您好，感谢您对公司的关注。目前，针对鼻病毒本身尚无特效抗病毒药物，临床以对症治疗为主。建议消费者应当根据实际情况遵照医嘱用药。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011600000570.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002728","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603679417","title":"特一药业：止咳宝片对慢性咳嗽临控+显效率达73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603679417","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603679417?lang=zh_cn&edition=full","pubTime":"2026-01-15 15:04","pubTimestamp":1768460653,"startTime":"0","endTime":"0","summary":"鼻病毒是引起普通感冒最常见的病原体，表现主要为鼻塞、流涕、咳嗽、咽痛及发热等上呼吸道症状。目前，针对鼻病毒本身尚无特效抗病毒药物，临床以对症治疗为主。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500019251.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728","BK0239","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602474853","title":"特一药业：暂未布局中药+脑机接口业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2602474853","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602474853?lang=zh_cn&edition=full","pubTime":"2026-01-09 15:00","pubTimestamp":1767942036,"startTime":"0","endTime":"0","summary":"证券之星消息，特一药业(002728)01月09日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司有脑机接口的技术相关储备没。中药脑机接口特一药业回复：您好，感谢您对公司的关注。公司目前暂未布局“中药+脑机接口”相关业务，但会持续关注该领域技术发展动态。未来若有相关业务规划，公司将严格按照信息披露规则及时履行公告义务。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900018708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002728","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602170347","title":"特一药业：2025年前三季度净利润同比增长985.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602170347","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602170347?lang=zh_cn&edition=full","pubTime":"2026-01-09 15:00","pubTimestamp":1767942036,"startTime":"0","endTime":"0","summary":"证券之星消息，特一药业01月09日在投资者关系平台上答复投资者关心的问题。2025年前三季度，公司实现营业总收入6.92亿元，同比增长51.86%；实现归属于上市公司股东的净利润6,521.71万元，同比增长985.18%。核心产品“特一”牌止咳宝片的销售稳步恢复，前三季度销量已恢复至2023年同期的64%，线上业务拓展也取得了积极成效。基于前三季度的经营态势，公司2025年年度经营情况符合内部规划预期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900018711.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602474873","title":"特一药业：止咳宝片研究已有阶段性成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2602474873","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602474873?lang=zh_cn&edition=full","pubTime":"2026-01-09 15:00","pubTimestamp":1767942035,"startTime":"0","endTime":"0","summary":"请问公司止咳宝片是否已开展医保申报的前期准备，比如临床数据梳理、竞品申报路径对标分析？公司核心产品止咳宝片具有百年历史，具有“宣肺祛痰、止咳平喘”之功效。近年来，公司已对止咳宝片治疗流感病毒感染后咳嗽及肺部炎症的药效机制和物质基础进行了研究，以及对止咳宝片在药理毒理、依赖性等方面进行了研究。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900018707.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","002728","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601800506","title":"特一药业涨5.07%，华安证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2601800506","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601800506?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:43","pubTimestamp":1767598995,"startTime":"0","endTime":"0","summary":"今日特一药业（002728）涨5.07%，收盘报11.4元。2025年11月18日，华安证券研究员谭国超发布了对特一药业的研报《营销体系改革完成，止咳宝片持续放量》，该研报对特一药业给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为42.51%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为光大证券的王明瑞。特一药业（002728）个股概况：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500015727.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728","600909"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601029338","title":"股市必读：特一药业（002728）12月31日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2601029338","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601029338?lang=zh_cn&edition=full","pubTime":"2026-01-05 02:00","pubTimestamp":1767549646,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，特一药业报收于10.85元，下跌1.09%，换手率4.72%，成交量17.8万手，成交额1.94亿元。董秘最新回复投资者： 对于禽流感，贵公司有无特效药？公司没有禽流感的特效药。针对该症状来看，公司药品涵盖了止咳、退热、抗生素、抗病毒药等类别。当日关注点来自交易信息汇总：12月31日主力资金净流出2464.3万元，占总成交额12.7%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500000611.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0239","002728"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1776344344919,"stockEarnings":[{"period":"1week","weight":-0.0142},{"period":"1month","weight":-0.0098},{"period":"3month","weight":-0.0314},{"period":"6month","weight":0.2503},{"period":"1year","weight":0.4516},{"period":"ytd","weight":0.0221}],"compareEarnings":[{"period":"1week","weight":0.0081},{"period":"1month","weight":-0.0141},{"period":"3month","weight":-0.0208},{"period":"6month","weight":0.0488},{"period":"1year","weight":0.2324},{"period":"ytd","weight":0.0147}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"特一药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"81515人(较上一季度增加6.07%)","perCapita":"4071股","listingDate":"2014-07-31","address":"广东省江门市台山市台城长兴路9、11号","registeredCapital":"51330万元","survey":"　　特一药业集团股份有限公司的主营业务是中成药品、化学制剂药品、化学原料药的研发、生产和销售。公司的主要产品是止咳宝片、感冒灵颗粒、血塞通分散片、银杏叶分散片、益心舒颗粒、铝碳酸镁咀嚼片、枫蓼肠胃康片、奥美拉唑肠溶胶囊、皮肤病血毒丸、小儿咳喘灵颗粒、金匮肾气片、降糖舒丸、独活寄生颗粒、脑乐静胶囊。公司及其全资子公司海力制药、新宁制药均为高新技术企业，同时公司被认定为省级企业技术中心。","listedPrice":14},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"特一药业(002728)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供特一药业(002728)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"特一药业,002728,特一药业股票,特一药业股票老虎,特一药业股票老虎国际,特一药业行情,特一药业股票行情,特一药业股价,特一药业股市,特一药业股票价格,特一药业股票交易,特一药业股票购买,特一药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"特一药业(002728)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供特一药业(002728)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}